HRT Financial’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

HRT Financial’s Portfolio SRGA Stock Details SRGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-96,529	Closed	-$17K	–	3439
2023 Q2	$17K	Buy	+96,529	New	+$92.6K	﹤0.01%	2117
2022 Q1	–	Sell	-391	Closed	-$8K	–	4178
2021 Q4	$8K	Buy	+391	New	+$10.5K	﹤0.01%	3039

Other funds holding SRGA

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

WWP

WR Wealth Planners Columbia, Missouri $311M AUM 18.22% 1-Year Est. Return

HRT Financial's SRGA Position: Q3 2023 in Review

HRT Financial sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q3 2023, closing a stake of 96,529 shares — an estimated $17K sold.

HRT Financial first reported a position in SRGA in Q4 2021 and held it in 2 quarters. The position peaked at $17K in Q2 2023. 4 funds tracked by Wall St. Rank hold SRGA as of Q3 2023.

HRT Financial reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
HRT Financial sold 96,529 Surgalign Holdings, Inc. Common Stock shares in Q3 2023, an estimated $17K.
HRT Financial first reported a position in Surgalign Holdings, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
HRT Financial's Surgalign Holdings, Inc. Common Stock position peaked at $17K in Q2 2023.
4 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q3 2023.

Based on HRT Financial's 13F filing for Q3 2023, filed 13 Nov 2023.